This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Evarrest
  • /
  • The Fibrin Pad CV Phase III Study
Clinical trial

The Fibrin Pad CV Phase III Study

Read time: 1 mins
Last updated:1st Jan 2014

The objective of this study is to evaluate the safety and effectiveness of the EVARREST™ Fibrin Sealant Patch as an adjunct to hemostasis during cardiovascular surgery.

Study Type: Interventional
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Enrollment: 156
Study Start Date: January 2014
Study Completion Date: September 2015
Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)

- Experimental:
EVARREST™ Fibrin Sealant Patch
- Active Comparator: Topical hemostat

Category Value
Study start date 2014-01-01

View full details